Last reviewed · How we verify
Infusion of placebo during 48 hours
Infusion of placebo during 48 hours is a Small molecule drug developed by University Hospital, Rouen. It is currently in Phase 3 development.
A placebo infusion serves as an inert control intervention with no active pharmacological mechanism.
At a glance
| Generic name | Infusion of placebo during 48 hours |
|---|---|
| Sponsor | University Hospital, Rouen |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Placebo is used in clinical trials as a control comparator to assess the efficacy of an active investigational treatment by isolating the true drug effect from natural disease progression and psychological expectation effects. The 48-hour infusion duration is a study design parameter rather than a mechanistic feature.
Approved indications
Common side effects
Key clinical trials
- Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial (PHASE3)
- Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy (PHASE1, PHASE2)
- A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer. (PHASE3)
- Perioperative Multimodal Analgesia Protocol for Supratentorial Craniotomy (NA)
- Ketamine Low dOse Evaluation on Morphine Consumption in Traumatic Patient (PHASE3)
- Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery (PHASE4)
- FMT for Lung and Associated-organ Rescue Efficacy in Pulmonary Infection With MDROs (NA)
- Interest of the Nefopam and PCA Morphine Combination for Postoperative Analgesia in Patients Undergoing Colon Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Infusion of placebo during 48 hours CI brief — competitive landscape report
- Infusion of placebo during 48 hours updates RSS · CI watch RSS
- University Hospital, Rouen portfolio CI